Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Shanghai Shende Non-Invasive Times Medical Technology

Explore full profile

Non-invasive ultrasound diagnosis and treatment systems

Huangpu, ChinaFounded 2013Health Tech & Medtech
Valuation $100–250M Last recorded · 2023
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Shanghai Shende Non-Invasive Times Medical Technology and the history behind them.

About Shanghai Shende Non-Invasive Times Medical Technology

Shanghai Shende Non-Invasive Times Medical Technology Co., Ltd. develops and manufactures non-invasive medical devices designed to treat major diseases and alleviate patient pain. The company was founded in May 2013, stemming from 25 years of research in Magnetic Resonance guided Phase-Controlled High-Intensity Focused Ultrasound (MRgPHIFU) by Academician Chen Yazhu of Shanghai Jiaotong University. The company is led by founder and Chairman Professor Shen Guofeng, with Cui Lei serving as Director and Executive CEO. General Counsel for the company is Academician Yazhu Chen, a member of the Chinese Academy of Engineering and a key pioneer of interdisciplinary medical engineering in China.

The firm's core business revolves around the commercialization of its independently developed MRgPHIFU technology, positioning itself as a domestic high-end medical device brand with full intellectual property rights. Shende Healthcare's product line includes systems for treating uterine fibroids, providing pain relief for metastatic bone tumors, and addressing conditions like Parkinson's, essential tumors, and gliomas through its Smart Transcranial system. Other products target prostate treatment, breast fibromas, and thyroid neoplasms. The business model is centered on providing comprehensive solutions to medical institutions, which includes the MRgPHIFU non-invasive integrated diagnosis and treatment center, a research support platform, and a medical college for physician training. The company serves hospitals and clinics, aiming to enhance treatment services and improve patient outcomes.

Since its inception, Shende Healthcare has achieved several milestones, including completing a Series A funding round of 30 million yuan in March 2019 and subsequent venture capital rounds, with the latest being a Series D in September 2023. The company has also established industrial bases and joint R&D centers to further its innovation. In November 2022, its 'Shende Green Medical Era' project won the top prize at the Global Internet Competition in Wuzhen.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2013
Headquarters
Huangpu, China
Employees
3
Open positions
None listed
Dealroom signal
26.5/100
Industry
Health
Sub-industry
Medical Devices
Sector
Health Tech & Medtech, Oncology, Surgery, Medical Imaging, Hard Tech, DT and LS, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
b2b

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES D✓Equity / VC Oct 2023 $28M $110M Dading Investment · Ningbo Jinming Chuangjia Investment · Hefei Industry Investment Group · Zhongli Fund ↗
SERIES BEquity / VC Jul 2021 $14M $55M Jianmu (Shanghai) Investment Management · SCI Advanced Technology Fund ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Shanghai Shende Non-Invasive Times Medical Technology website traffic

Latest recorded traffic for Shanghai Shende Non-Invasive Times Medical Technology is 290 monthly website visits, up 1350% over the last three months. Shanghai Shende Non-Invasive Times Medical Technology's team declined 40% over the past year.

Latest monthly visits290 3-month web change+1350% 1-year team growth-40%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

  • Jianmu (Shanghai) Investment Management
  • SCI Advanced Technology Fund

Series B and later4 investors entered at this stage

  • Dading Investment
  • Ningbo Jinming Chuangjia Investment
  • Hefei Industry Investment Group
  • Zhongli Fund
Employees 3 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇨🇳 China100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Shanghai Shende Non-Invasive Times Medical Technology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Shanghai Shende Non-Invasive Times Medical Technology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.